Avagenesis Corp Announces Canadian Notice of Patent Allowance

[The notice] is for a patent application on adipose cell isolation technology.  The Company anticipates the patent to be issued within 60 days.  

 

Once that occurs, patents will have been issued on the Company’s licensed technology in a total of eight jurisdictions (the others being the United States, Australia, Singapore, Russia, Japan, South Korea and China). Avagenesis expects more patent issuances internationally over the next 18 months.